Literature DB >> 14656693

Cytokine patterns during dengue shock syndrome.

Catharina Suharti1, Eric C M van Gorp, Wil M V Dolmans, Tatty E Setiati, C Erik Hack, Robert Djokomoeljanto, Jos W M van der Meer.   

Abstract

OBJECTIVE: To investigate the patterns of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), IL-6, interferon-gamma (IFN-gamma) and interleukin-1 receptor antagonist (IL-1Ra) during the course of dengue shock syndrome.
DESIGN: Prospective clinical study.
SETTING: Pediatric Intensive Care Unit, Dr. Kariadi Hospital, the university hospital of Diponegoro University, Semarang, Indonesia. PATIENTS: Fifty children with dengue shock syndrome. MEASUREMENTS: The plasma concentration and the ex vivo production, with and without lipopolysaccharide (LPS), of TNF-alpha, IL-1beta and IL-1Ra were measured in duplicate by nonequilibrium radioimmunoassay (RIA); IFN-gamma and IL-6 were measured by ELISA.
RESULTS: During the acute phase, the plasma concentrations and the ex vivo production without LPS of IL-1Ra were considerably elevated and returned to normal on recovery. However, the ex vivo LPS-stimulated production of the proinflammatory cytokines TNF-alpha and IL-1beta were considerably depressed. Also, these concentrations returned towards normal on recovery. In non-survivors, the plasma concentrations of IL-6 and IL-1Ra were significantly higher than in survivors (p = 0.00001 and p = 0.0005, respectively). In addition, the ex vivo production of IL-1Ra in non-survivors was significantly higher than in survivors, both without LPS stimulation (p = 0.0008) and with LPS (p < 0.004). IL-1Ra was significantly associated with mortality (p = 0.007).
CONCLUSION: Since IL-1Ra was significantly associated with mortality, this measurement may be used as an index of disease severity in dengue shock syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656693

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  20 in total

1.  Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.

Authors:  Natalia Frias-Staheli; Marcus Dorner; Svetlana Marukian; Eva Billerbeck; Rachael N Labitt; Charles M Rice; Alexander Ploss
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 2.  Dengue virus life cycle: viral and host factors modulating infectivity.

Authors:  Izabela A Rodenhuis-Zybert; Jan Wilschut; Jolanda M Smit
Journal:  Cell Mol Life Sci       Date:  2010-04-06       Impact factor: 9.261

Review 3.  The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.

Authors:  Dustin R Glasner; Henry Puerta-Guardo; P Robert Beatty; Eva Harris
Journal:  Annu Rev Virol       Date:  2018-07-25       Impact factor: 10.431

4.  Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1.

Authors:  Carlos A Sariol; Jorge L Muñoz-Jordán; Kristina Abel; Lymarie C Rosado; Petraleigh Pantoja; Luis Giavedoni; Idia Vanessa Rodriguez; Laura J White; Melween Martínez; Teresa Arana; Edmundo N Kraiselburd
Journal:  Clin Vaccine Immunol       Date:  2007-04-11

5.  Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques.

Authors:  Carlos A Sariol; Melween I Martínez; Francheska Rivera; Idia Vanessa Rodríguez; Petraleigh Pantoja; Kristina Abel; Teresa Arana; Luis Giavedoni; Vida Hodara; Laura J White; Yesseinia I Angleró; Luis J Montaner; Edmundo N Kraiselburd
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

Review 6.  Role of microparticles in dengue virus infection and its impact on medical intervention strategies.

Authors:  Kristina Bargeron Clark; Hui-Mien Hsiao; Sansanee Noisakran; Jih-Jin Tsai; Guey Chuen Perng
Journal:  Yale J Biol Med       Date:  2012-03-29

7.  Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease.

Authors:  Cornelia A M van de Weg; Cláudio S Pannuti; Evaldo S A de Araújo; Henk-Jan van den Ham; Arno C Andeweg; Lucy S V Boas; Alvina C Felix; Karina I Carvalho; Andreia M de Matos; José E Levi; Camila M Romano; Cristiane C Centrone; Celia L de Lima Rodrigues; Expedito Luna; Eric C M van Gorp; Albert D M E Osterhaus; Byron E E Martina; Esper G Kallas
Journal:  PLoS Negl Trop Dis       Date:  2013-05-23

8.  Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease.

Authors:  Silvia Torres; Juan Carlos Hernández; Diana Giraldo; Margarita Arboleda; Mauricio Rojas; Jolanda M Smit; Silvio Urcuqui-Inchima
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

9.  Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome.

Authors:  Thi Phuong Lan Nguyen; Mihoko Kikuchi; Thi Que Huong Vu; Quang Ha Do; Thi Thuy Tran; Dinh Tham Vo; Manh Tuan Ha; Van Tuong Vo; Thi Phi Nga Cao; Van Dat Tran; Toshifumi Oyama; Kouichi Morita; Michio Yasunami; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2008-10-01

10.  Differential gene expression changes in children with severe dengue virus infections.

Authors:  Martijn D de Kruif; Tatty E Setiati; Albertus T A Mairuhu; Penelopie Koraka; Hella A Aberson; C Arnold Spek; Albert D M E Osterhaus; Pieter H Reitsma; Dees P M Brandjes; Augustinus Soemantri; Eric C M van Gorp
Journal:  PLoS Negl Trop Dis       Date:  2008-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.